Rare
lephants
Screener
Toggle theme
Alcon Inc.
ALC
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations:
$1.23B
Line Item
Value
% of Total
Capital Expenditures
$415.0M
33.8%
Other Investing
$264.0M
21.5%
Other Financing
$539.0M
43.9%
Net Cash Flow
$10.0M
0.8%
